header
Image from OpenLibrary

Evaluation of the therapeutic effects of proton pump inhibitorsand Spirulina Platensis on non-alcoholic fatty liver disease in rats / Rouaina Mohamad Hassan Elshamy ; Supervised Noha Ahmed Elboghdady , Maher Abdelnaby Kamel

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Rouaina Mohamad Hassan Elshamy , 2021Description: 105 P. : charts , facsimiles ; 25cmOther title:
  • تقييم التأثيرات العلاجية لمثبطات مضخة البروتون و السبيرولينا بلاتينسيس فى مرض التهاب الكبد الدهنى الغير كحولى فى الجرذان [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Biochemistry Summary: Background: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of liver damage, and it affects about 24% of the population worldwide.This study aimed to investigate the effect of omeprazole and spirulina platensis on hepatic and serum biochemical alterations in NAFLD induced by high-fat diet (HFD). Methods: 40 Male Wistar rats were divided into 4 groups; one served as a normal control.The other groups received HFD and subdivided into 3 subgroups; one was left untreated; the other 2 groups were treated orally with omeprazole (10 mg/kg) and spirulina (1000 mg/kg) for 30 consecutive days. Results: Omeprazole successfully decreased elevated serum pentraxin-3 (PTX-3) and cytokeratin-18 (CK-18) levels and hepatic sterol regulatory element binding protein-1c (SREBP-1c) expression, while spirulina had better impact on improving liver function enzymes, lipid profile and nuclear factor erythroid 2{u2013}related factor 2 (Nrf-2) levels compared to omeprazole. Both treatments had similar effects on normalizing glucose homeostasis, decreasing insulin resistance and improving adipocytokines levels.Conclusion: Effects of omeprazole and spirulina on markers of NAFLD appeared to be mediated by regulation of inflammatory, apoptotic and oxidative mediators.Thus, omeprazole and spirulina may find use as promising adjuvant therapy to ameliorate NAFLD
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.01.Ph.D.2021.Ro.E (Browse shelf(Opens below)) Not for loan 01010110084227000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.01.Ph.D.2021.Ro.E (Browse shelf(Opens below)) 84227.CD Not for loan 01020110084227000

Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Biochemistry

Background: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of liver damage, and it affects about 24% of the population worldwide.This study aimed to investigate the effect of omeprazole and spirulina platensis on hepatic and serum biochemical alterations in NAFLD induced by high-fat diet (HFD). Methods: 40 Male Wistar rats were divided into 4 groups; one served as a normal control.The other groups received HFD and subdivided into 3 subgroups; one was left untreated; the other 2 groups were treated orally with omeprazole (10 mg/kg) and spirulina (1000 mg/kg) for 30 consecutive days. Results: Omeprazole successfully decreased elevated serum pentraxin-3 (PTX-3) and cytokeratin-18 (CK-18) levels and hepatic sterol regulatory element binding protein-1c (SREBP-1c) expression, while spirulina had better impact on improving liver function enzymes, lipid profile and nuclear factor erythroid 2{u2013}related factor 2 (Nrf-2) levels compared to omeprazole. Both treatments had similar effects on normalizing glucose homeostasis, decreasing insulin resistance and improving adipocytokines levels.Conclusion: Effects of omeprazole and spirulina on markers of NAFLD appeared to be mediated by regulation of inflammatory, apoptotic and oxidative mediators.Thus, omeprazole and spirulina may find use as promising adjuvant therapy to ameliorate NAFLD

Issued also as CD

There are no comments on this title.

to post a comment.